Massive hope for pancreatic cancer pill after trial saw tumours vanish
AI Image

Massive hope for pancreatic cancer pill after trial saw tumours vanish

BBC • • general

Key Points:

  • A new daily pill, daraxonrasib, combined with chemotherapy, has shown promising results in shrinking or potentially eliminating tumors in some patients with advanced pancreatic cancer, one of the deadliest and hardest-to-treat cancers.
  • In early trials involving 61 patients, tumors stopped growing in nearly all participants, and cancer became undetectable on scans in about one in 12 patients, though the long-term effectiveness remains uncertain.
  • Daraxonrasib is a KRAS inhibitor targeting RAS mutations common in pancreatic and other cancers, offering hope for broader applications beyond pancreatic cancer.
  • Experts emphasize that while the results are encouraging and may improve survival and disease control, longer studies are needed to determine if the cancer can be put into remission and for how long.
  • The breakthrough is being hailed as a significant advancement in treating pancreatic cancer, with potential to extend patients' lives even if it does not provide a definitive cure.

Trending Business

Trending Technology

Trending Health